Jun 14, 2021 Clinical Genomics Announces Three Poster Presentations at ASCO 2021 Annual Meeting, Including New Data Highlighting Clinical Utility of COLVERA® Liquid Biopsy for Colorectal Cancer Recurrence Detection and Prediction of Clinical Outcomes
Nov 19, 2020 Presentation by Clinical Genomics CEO, Betsy Hanna, at Canaccord Genuity Virtual Medical Technologies and Diagnostics Forum
Nov 10, 2020 Clinical Genomics to Present at 2020 Canaccord Genuity Virtual Medical Technologies & Diagnostics Forum
Sep 22, 2020 Clinical Genomics Announces Publication of Additional Clinical Data for COLVERA® Recurrence monitoring Blood Test for Colorectal Cancer Patients
May 27, 2020 Clinical Genomics Announces Publication of Additional Positive Data Reinforcing Key Benefits of COLVERA®, Blood Test for the Recurrence Monitoring of Colorectal Cancer in Cancer, an American Cancer Society Journal
Apr 30, 2020 Clinical Genomics Expands Strategic Relationship with Quest Diagnostics and Further Increases Momentum for Innovative First-Line Colorectal Cancer Screening Blood Test
